Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience by Giulia Scioscia, Giulia Scioscia, Giovanna Elisiana Carpagnano, Carla Maria Irene Quarato, Carla Maria Irene Quarato, Donato Lacedonia, Donato Lacedonia, Sonia Santamaria, Sonia Santamaria, Piera Soccio, Annarita Depalo, Paolo Fuso, Paolo Fuso, Maria Pia Foschino Barbaro, Maria Pia Foschino Barbaro

Connect to this object online.

Clinical Efficacy of Carbocysteine in COPD: Beyond the Mucolytic Action by Elisabetta Pace, Isa Cerveri, Donato Lacedonia, Gregorino Paone, Alessandro Sanduzzi Zamparelli, Rossella Sorbo, Marcello Allegretti, Luigi Lanata, Francesco Scaglione

Connect to this object online.

Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study by Giovanna Elisiana Carpagnano, Francesco Sessa, Giulia Scioscia, Donato Lacedonia, Maria Pia Foschino, Maria Pia Venuti, Antonio Ivano Triggiani, Anna Valenzano, Onofrio Resta, Giuseppe Cibelli, Giovanni Messina

Connect to this object online.

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region by Emanuela Resta, Giulia Scioscia, Donato Lacedonia, Carla Maria Irene Quarato, Francesco Panza, Onofrio Resta, Giorgia Lepore, Enrico Buonamico, Valentina Di Lecce, Giovanna Elisiana Carpagnano, Maria Pia Foschino Barbaro, Noemi Rossi

Connect to this object online.